|
1
|
Gu J, Wang Y and Wu X: MicroRNA in the
pathogenesis and prognosis of esophageal cancer. Curr Pharm Des.
19:1292–1300. 2013.PubMed/NCBI
|
|
2
|
Yang M, Liu R, Sheng J, et al:
Differential expression profiles of microRNAs as potential
biomarkers for the early diagnosis of esophageal squamous cell
carcinoma. Oncol Rep. 29:169–176. 2013.PubMed/NCBI
|
|
3
|
Liu F, Zheng S, Liu T, et al: MicroRNA-21
promotes the proliferation and inhibits apoptosis in Eca109 via
activating ERK1/2/MAPK pathway. Mol Cell Biochem. 381:115–125.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang M, Li Y, Liu W, et al: miR-129–2
suppresses proliferation and migration of esophageal carcinoma
cells through downregulation of SOX4 expression. Int J Mol Med.
32:51–58. 2013.
|
|
5
|
Liu T, Tang H, Lang Y, Liu M and Li X:
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by
targeting prohibitin. Cancer Lett. 273:233–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Z, Liu S, Shi R and Zhao G: miR-27
promotes human gastric cancer cell metastasis by inducing
epithelial-to-mesenchymal transition. Cancer Genet. 204:486–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a~27a~24-2 cluster and its implication in human diseases. Mol
Cancer. 9:2322010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saumet A, Vetter G, Bouttier M, et al:
Transcriptional repression of microRNA genes by PML-RARA increases
expression of key cancer proteins in acute promyelocytic leukemia.
Blood. 113:412–421. 2009. View Article : Google Scholar
|
|
9
|
Xi Y, Shalgi R, Fodstad O, Pilpel Y and Ju
J: Differentially regulated micro-RNAs and actively translated
messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Clin Cancer Res. 12:2014–2024. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dai Y, Sui W, Lan H, Yan Q, Huang H and
Huang Y: Comprehensive analysis of microRNA expression patterns in
renal biopsies of lupus nephritis patients. Rheumatol Int.
29:749–754. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kozaki K, Imoto I, Mogi S, Omura K and
Inazawa J: Exploration of tumor-suppressive microRNAs silenced by
DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prueitt RL, Yi M, Hudson RS, et al:
Expression of microRNAs and protein-coding genes associated with
perineural invasion in prostate cancer. Prostate. 68:1152–1164.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Acunzo M, Romano G, Palmieri D, et al:
Cross-talk between MET and EGFR in non-small cell lung cancer
involves miR-27a and Sprouty2. Proc Natl Acad Sci USA.
110:8573–8578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Cheng B, Miao L, Mei Y and Wu M:
Mutant p53-R273H gains new function in sustained activation of EGFR
signaling via suppressing miR-27a expression. Cell Death Dis.
4:e5742013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang H, Li M, Han Y, et al:
Down-regulation of miR-27a might reverse multidrug resistance of
esophageal squamous cell carcinoma. Dig Dis Sci. 55:2545–2551.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu C, Chen K, Zheng H, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reyes M, Lund T, Lenvik T, Aguiar D,
Koodie L and Verfaillie CM: Purification and ex vivo expansion of
postnatal human marrow mesodermal progenitor cells. Blood.
98:2615–2625. 2001. View Article : Google Scholar
|
|
19
|
Edgar R, Domrachev M and Lash AE: Gene
expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mathe EA, Nguyen GH, Bowman ED, et al:
MicroRNA expression in squamous cell carcinoma and adenocarcinoma
of the esophagus: associations with survival. Clin Cancer Res.
15:6192–6200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Campbell PM, Groehler AL, Lee KM,
Ouellette MM, Khazak V and Der CJ: K-Ras promotes growth
transformation and invasion of immortalized human pancreatic cells
by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res.
67:2098–2106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Downward J: Targeting RAS signalling
pathways in cancer therapy. Nat Rev Cancer. 3:11–22. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu S, Lu Z, Liu C, et al: miRNA-96
suppresses KRAS and functions as a tumor suppressor gene in
pancreatic cancer. Cancer Res. 70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lyronis ID, Baritaki S, Bizakis I,
Krambovitis E and Spandidos DA: K-ras mutation, HPV infection and
smoking or alcohol abuse positively correlate with esophageal
squamous carcinoma. Pathol Oncol Res. 14:267–273. 2008. View Article : Google Scholar : PubMed/NCBI
|
